{
    "name": "hydrocortisone/neomycin/polymyxin otic",
    "comment": "Rx",
    "other_names": [
        "Cortisporin Otic"
    ],
    "classes": [
        "Antibiotics/Corticosteroids",
        "Otic"
    ],
    "source": "https://reference.medscape.com/drug/cortisporin-otic-hydrocortisone-neomycin-polymyxin-otic-343649",
    "pregnancy": {
        "common": [
            "Pregnancy category: C",
            "Lactation: Unknown whether drug is excreted in milk; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown whether drug is excreted in milk; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to any agent",
                "Cutaneous viral infection of the external auditory canal (solution only); patients with herpes simplex, vaccinia, and varicella infections"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Neomycin sensitization, including itching, reddening, edema, and failure to heal may occur; discontinue therapy if it occurs",
                "Solution does not penetrate quite as well as suspension does",
                "Systemic absorption of topical corticosteroids may cause hypothalamic-pituitary-adrenal axis suppression, which may lead to adrenal crisis, especially in children and in patients receiving large doses for prolonged periods",
                "Prolonged use of corticosteroids may increase the incidence of secondary infection, mask acute infection, and may also prolong or exacerbate viral infections ",
                "Development of Kaposi sarcoma associated with prolonged treatment with corticosteroids; discontinue therapy if it occurs",
                "Neomycin can induce permanent sensorineural hearing loss due to cochlear damage, including destruction of hair cells in the organ of Corti; risk of ototoxicity is greater with prolonged use",
                "Percutaneous absorption of topical corticosteroids may occur, which may cause manifestations of hyperglycemia, Cushing syndrome, or glycosuria; use of occlusive dressings, application fo denuded skin, or application to large surface areas may increase risk of absorption"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Itching",
            "percent": null
        },
        {
            "name": "Redness",
            "percent": null
        },
        {
            "name": "Skin rash",
            "percent": null
        },
        {
            "name": "Swelling",
            "percent": null
        }
    ]
}